Skip to main content
Keith Bible, MD, Oncology, Rochester, MN

KeithCBibleMDPhD

Oncology Rochester, MN

Endocrine Cancer, Gynecologic Cancer, Hematologic Oncology

Professor of Oncology, Mayo Medical School; Consultant in Medical Oncology, Department of Oncology, Mayo Clinic

Dr. Bible is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Bible's full profile

Already have an account?

  • Office

    200 1st St SW
    Rochester, MN 55905
    Phone+1 507-284-2511
    Fax+1 605-720-7171

Education & Training

  • Mayo Clinic College of Medicine
    Mayo Clinic College of MedicinePost-Doctoral Fellowship, 1995 - 1997
  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 1992 - 1995
  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1989 - 1992
  • University of Illinois at Urbana-Champaign
    University of Illinois at Urbana-ChampaignPhD, Chemistry, 1983 - 1989
  • University of Illinois College of Medicine
    University of Illinois College of MedicineClass of 1983
  • Washington University in St. Louis
    Washington University in St. LouisB.S./A.B., Chemistry&Anthropology, Phi Beta Kappa, 1976 - 1979

Certifications & Licensure

  • MN State Medical License
    MN State Medical License 1990 - 2025

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Novel Treatments, Effective Combinations Still Needed in Thyroid Cancer
    Novel Treatments, Effective Combinations Still Needed in Thyroid CancerMay 26th, 2016
  • Study to Treat Deadly Form of Thyroid Cancer Shows Promise
    Study to Treat Deadly Form of Thyroid Cancer Shows PromiseApril 18th, 2013

Grant Support

  • Flavopiridol Reverses Platinum Resistance In Ovarian CancerNational Cancer Institute2009–2011
  • Chaetocin As A Potential Therapy For Multiple MyelomaNational Cancer Institute2008–2011
  • Flavopiridol Targets Transcription Factor/Dna ComplexesNational Cancer Institute2004–2006
  • Flavopiridol As A Potential Therapy In Multiple MyelomaNational Cancer Institute2004–2005
  • Flavopiridol Targets Transcription Factor/Dna ComplexesNational Cancer Institute2003
  • Flavopiridol As A Potential Therapy In Multiple MyelomaNational Cancer Institute2003
  • Phase I: Flavopiridol And Cisplatin In Advanced CancerNational Center For Research Resources2000–2002

Professional Memberships